Dr. Saeid Ferdousmakan | Health Professions | Best Researcher Award

Saied Ferdousmakan is a dedicated clinical pharmacist and researcher with a strong background in oncology, pharmacology, and medication safety. He earned his Doctor of Pharmacy (PharmD) degree from Rajiv Gandhi University of Health Sciences, Bengaluru, India, where he focused on medication safety in obstetrics and gynecology. His research interests are centered on miRNA-based therapeutic strategies for cancer, particularly liver cancer and melanoma, as well as autophagy mechanisms and immunotherapies. Saied’s expertise is further enhanced by practical experience as a clinical pharmacist, having worked in both India and Iran. He is committed to advancing cancer research and therapeutic interventions, actively contributing to scientific literature through publications and conference presentations. Saied is also engaged in continuous professional development, attending workshops on topics like molecular biology, immunoinformatics, and oncology. His soft skills in leadership, communication, and public speaking add to his overall capability as a researcher and healthcare professional.

Professional Profile

• Google Scholar

Education:

Saied Ferdousmakan holds a Doctor of Pharmacy (PharmD) degree from Rajiv Gandhi University of Health Sciences in Bengaluru, India, where he completed his studies from July 2013 to May 2019. His academic journey was marked by a focus on pharmacy, where he earned a GPA of 2870 out of 4500, recognized as a first division. His PharmD thesis, titled Medication Safety in Obstetrics and Gynecology Ward in Jayanagar General Hospital, Bangalore, highlighted his commitment to improving healthcare practices. His education laid the foundation for his ongoing research in therapeutic strategies and clinical pharmacy.

Professional Experience:

Saied’s professional career spans clinical pharmacy and research. From January 2023 to March 2024, he worked as a Clinical Pharmacist at Daryan Hospital in Iran, where he provided direct patient care and contributed to medication management. Prior to this, he completed an internship at Jayanagar General Hospital in India from July 2019 to July 2020. His role involved enhancing patient care and improving safety protocols in the hospital’s general medicine department. This clinical experience has strengthened his practical understanding of drug therapy, which complements his research focus.

Research Interests:

Saied Ferdousmakan’s primary research interests lie in the design and application of miRNA-based therapies for cancer, with a special focus on liver cancer. His work investigates miR-148a-3p as a negative regulator of glycometabolism and cell proliferation in liver cancer cells. Additionally, he explores the role of Ambra1 protein in autophagy, which contributes to drug resistance and cancer progression, particularly in melanoma. Saied is also involved in studying immunotherapies targeting CTLA-4 and PD-1 in melanoma, as well as developing inhibitors like PKC and C-Met for treating uveal melanoma. His interest extends to stem cell research and using NOV/CCN3 proteins to enhance hematopoietic stem cell function, particularly in cord blood units.

Research Skills:

Saied possesses strong research skills in molecular biology, immunotherapy, and pharmacology. His expertise in designing miRNA-based therapeutic strategies and his understanding of cancer biology, particularly in melanoma and liver cancer, reflect his solid foundation in experimental design. He is proficient in laboratory techniques such as PCR, cell culture, and Western blotting, which are crucial for his studies in autophagy and drug resistance. Additionally, Saied is skilled in statistical analysis and the use of bioinformatics tools like R for analyzing complex datasets. His involvement in international research conferences further attests to his ability to communicate complex scientific findings to diverse audiences.

Awards and Honors:

While specific awards and honors are not explicitly listed, Saied has made significant contributions to research and academia, as evidenced by his publications in reputable journals such as Cancer Cell International and Pak. J. Med. Health Sci., as well as his presentations at international conferences. His ongoing research in cancer treatment and medication safety has been well-received in academic circles. Additionally, his active participation in professional workshops and continuous learning showcases his commitment to personal and professional growth. These factors, combined with his practical work experience and leadership abilities, suggest that Saied is on track for future recognition in his field.